Veritas Pharma Inc. announced earnings results for the second quarter ended October 31, 2019. For the second quarter, the company announced operating loss was CAD 255,439 compared to CAD 1.235 million a year ago. Net loss was CAD 255,439 compared to CAD 1.199 million a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.17 a year ago. For the half year, operating loss was CAD 1.153 million compared to CAD 1.988 million a year ago. Net loss was CAD 1.153 million compared to CAD 1.953 million a year ago. Basic loss per share was CAD 0.09 compared to CAD 0.28 a year ago.